文献速递静脉血栓栓塞

下腔静脉滤器对肺栓塞相关死亡率及主要并发症的影响:随机对照试验的系统综述与荟萃分析

Effect of inferior vena cava filters on pulmonary embolism-related mortality and major complications: a systematic review and meta-analysis of randomized controlled trials.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-02-19

该系统综述与荟萃分析纳入7项随机对照试验共1274例患者,评估下腔静脉滤器的获益与风险。结果显示滤器未显著降低肺栓塞相关死亡率,但可减少新发肺栓塞,且不增加深静脉血栓或大出血风险。

要点

  • 滤器组3个月内新发肺栓塞率低于对照组(0.81% vs 5.98%,RR 0.17,95%CI 0.04-0.65,P=0.01)。

核心结论

  • 证据不足以认定下腔静脉滤器可降低死亡率。
  • 使用下腔静脉滤器减少了新发肺栓塞,且未增加深静脉血栓或大出血。

研究设计与样本

  • 共纳入7篇文章,1274例患者。

主要发现

  • 整个随访期肺栓塞相关死亡率无显著差异,异质性低(I2=0%)。
  • 3个月内新发肺栓塞滤器组低于对照组(0.81% vs 5.98%,RR 0.17,95%CI 0.04-0.65,P=0.01)。

临床怎么用

  • 下腔静脉滤器可考虑用于减少新发肺栓塞,但不应期望其降低死亡率。
  • 临床决策需权衡滤器减少肺栓塞的获益与未证实死亡率获益之间的平衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Inferior vena cava (IVC) filters are often used. However, no clear consensus has been reached regarding the benefits and risks from randomized, controlled trials. Therefore, we investigated benefits and risks of IVC filter use. METHODS: The PubMed and Cochrane Library databases were searched from inception to October 31, 2019 to identify randomized, controlled trials for inclusion in our meta-analysis. The primary outcome was mortality related to pulmonary embolism (PE). The secondary outcomes were overall mortality, PE, deep vein thrombosis, and major bleeding. Risk ratios were pooled using the Mantel-Haenszel method with the fixed effects model for low heterogeneity. Otherwise, the random effects model was used. Risk differences were considered candidates of effect size if some of the data could not be pooled in the calculations. RESULTS: Seven articles with 1274 patients were included. We found no significant difference in mortality related to PE between the IVC filter and control groups within 3 months (risk difference, -0.01; 95% confidence interval, -0.03 to 0.00; P = .11) nor during the entire follow-up period with low heterogeneity (I2 = 0%). The new occurrence of PE within 3 months and during the whole follow-up period was lower in the IVC filter group than in the control group (0.81% vs 5.98%; risk ratio, 0.17; 95% CI, 0.04-0.65; P = .01; and 3.2% vs 7.79%; risk ratio, 0.42; 95% CI, 0.25-0.71; P = .001, respectively). No significant differences were found in the rates of the new occurrence of deep vein thrombosis, major bleeding, and mortality during the whole follow-up period between the two groups (P > .05). CONCLUSIONS: We found insufficient evidence to conclude that the use of IVC filters can reduce mortality. However, the use of IVC filters decreased the new occurrence of PE without increasing deep vein thrombosis or major bleeding.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Liu Y, Lu H, Bai H, et al. Effect of inferior vena cava filters on pulmonary embolism-related mortality and major complications: a systematic review and meta-analysis of randomized controlled trials. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33618066. doi:10.1016/j.jvsv.2021.02.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。